Talkiatry key facts
as of Oct 2026- Provider of mental health care services intended to expand access to treatment opportunities.
- Talkiatry is valued at approximately $1.4B as of Oct 2026 (last reported valuation).
- It has raised $429.0M; the latest was Later Stage VC ($210.0M) in Feb 2026.
- Notable investors include Y Combinator, Andreessen Horowitz, General Catalyst, Gaingels, Left Lane Capital — 15 tracked in total.
- Status: Privately Held (backing).
Talkiatry's last reported valuation, Feb 2026. Nothing priced has surfaced since.
- ·The complete investor list: 15 names
- ·Watch Talkiatry: the Monday email on marks, rounds and moves
Talkiatry funding rounds
No funding rounds for Talkiatry are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Talkiatry
15+Talkiatry valuation
Talkiatry's last reported valuation was $1.4 billion in Feb 2026. No priced round, secondary trade or fund mark has surfaced since.
Talkiatry investors
15 investors are on record for Talkiatry, including Y Combinator, Andreessen Horowitz, General Catalyst and Gaingels. By type, the record holds 5 venture capital firms, 1 hedge fund and 1 fund of funds.
About Talkiatry
Provider of mental health care services intended to expand access to treatment opportunities. The company utilizes an interactive process with evidence-based scales to offer a preliminary diagnosis and severity on the spot, enabling people to easily seek in-network and quality healthcare.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2019
- Employees
- 601
- Website
- talkiatry.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.